Insider Transactions in Q4 2022 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.7%
|
$112,000
$14.57 P/Share
|
|
Dec 16
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
535
-0.05%
|
$8,025
$15.01 P/Share
|
|
Dec 15
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.14%
|
$70,000
$14.64 P/Share
|
|
Dec 14
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
6,420
-0.56%
|
$96,300
$15.08 P/Share
|
|
Dec 02
2022
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
1,154
-7.76%
|
$18,464
$16.9 P/Share
|
|
Dec 02
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,154
-11.68%
|
$18,464
$16.9 P/Share
|
|
Dec 01
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,165
-10.55%
|
$18,640
$16.75 P/Share
|
|
Dec 01
2022
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
1,164
-7.26%
|
$18,624
$16.75 P/Share
|
|
Nov 30
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,182
-9.67%
|
$18,912
$16.5 P/Share
|
|
Nov 30
2022
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
1,183
-6.87%
|
$18,928
$16.5 P/Share
|
|
Nov 29
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,251
+45.61%
|
-
|
|
Nov 29
2022
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,251
+37.31%
|
-
|
|
Nov 17
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.21%
|
$80,000
$16.54 P/Share
|
|
Nov 16
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.35%
|
$136,000
$17.06 P/Share
|
|
Nov 15
2022
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,857
-12.12%
|
$116,569
$17.72 P/Share
|
|
Nov 10
2022
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
8,382
+33.72%
|
-
|
|
Nov 10
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-33.33%
|
-
|
|
Nov 09
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.77%
|
$153,000
$17.87 P/Share
|
|
Oct 20
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.23%
|
$80,000
$16.26 P/Share
|
|
Oct 19
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.34%
|
$136,000
$17.26 P/Share
|
|
Oct 12
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.38%
|
$144,000
$16.0 P/Share
|